Surterra Wellness Expands Line of Medical Cannabis Tinctures in Texas
Marijuana Industry News June 30, 2020 MJ Shareholders
AUSTIN, Texas, June 30, 2020 /CNW/ -PRESS RELEASE- Surterra Wellness, a medical cannabis retail and product brand, today announced an expansion of its line of medical cannabis tinctures for patients across the state of Texas. The new tinctures are available immediately for delivery across the state.
Surterra has introduced two new therapeutic tinctures and has revamped its existing line including; Tranquil, a 19:1 CBD:THC ratio, Serene, a 4:1 CBD:THC ratio and Soothe, a 1:1 CBD:THC ratio. Each of the tincture blends has been formulated with proprietary terpene profiles to enhance the experience of the cannabinoid ratios.
“We are thrilled to expand our Surterra Wellness product line of medical tinctures in the Texas market to provide patients with high-quality, plant-based cannabis products formulated for conditions such as cancer, autism, spasticity, epilepsy, and neurodegenerative diseases,” said Marcus Ruark, President of Surterra Wellness. “We are committed to making natural and effective medical cannabis products accessible to patients across Texas.”
Surterra’s parent company, Parallel, is a healthcare product manufacturer and retailer. The company has operations in Texas, Florida, Nevada and Massachusetts, Parallel is one of the largest providers of medical, wellness and lifestyle cannabis products in the United States.
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
